{"filing":{"accession_number":"0001023024-26-000056","cik":"0001023024","ticker":"ANIP","company_name":"ANI PHARMACEUTICALS INC","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"ani-20260521.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000056/ani-20260521.htm"},"events":[{"id":9284,"run_id":8144,"accession_number":"0001023024-26-000056","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"ANI Pharmaceuticals held its Annual Meeting of Stockholders on May 21, 2026, and disclosed complete voting results on five proposals including director elections, auditor ratification, say-on-pay votes, and approval of an Amended and Restated 2022 Stock Incentive Plan.","company_name":"ANI PHARMACEUTICALS INC","ticker":"ANIP","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":865,"accession_number":"0001023024-26-000056","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses stockholder approval of an Amended and Restated 2022 Stock Incentive Plan at the Annual Meeting on May 21, 2026. This is a compensatory arrangement affecting directors and officers, falling squarely within the exec_compensation category. The amendment to a stock incentive plan is material to investors as it affects equity compensation structures and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:29:25.754282+00:00","company_name":"","ticker":null,"filing_date":""},{"id":866,"accession_number":"0001023024-26-000056","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the complete results of ANI Pharmaceuticals' Annual Meeting of Stockholders, including voting outcomes on director elections, auditor ratification, say-on-pay proposals, and stock plan approval. The detailed vote tallies for all five proposals are the core content, making this a textbook shareholder_vote_results event. The materiality is high because director elections and equity plan approvals directly affect governance and shareholder interests.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:29:25.754282+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":865,"accession_number":"0001023024-26-000056","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses stockholder approval of an Amended and Restated 2022 Stock Incentive Plan at the Annual Meeting on May 21, 2026. This is a compensatory arrangement affecting directors and officers, falling squarely within the exec_compensation category. The amendment to a stock incentive plan is material to investors as it affects equity compensation structures and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:29:25.754282+00:00","company_name":"ANI PHARMACEUTICALS INC","ticker":"ANIP","filing_date":"2026-05-21"},{"id":866,"accession_number":"0001023024-26-000056","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the complete results of ANI Pharmaceuticals' Annual Meeting of Stockholders, including voting outcomes on director elections, auditor ratification, say-on-pay proposals, and stock plan approval. The detailed vote tallies for all five proposals are the core content, making this a textbook shareholder_vote_results event. The materiality is high because director elections and equity plan approvals directly affect governance and shareholder interests.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:29:25.754282+00:00","company_name":"ANI PHARMACEUTICALS INC","ticker":"ANIP","filing_date":"2026-05-21"}]}